ATE141054T1 - Verwendung von hyaluronsäure und derivate zur vorbeugung arterieller restenose - Google Patents

Verwendung von hyaluronsäure und derivate zur vorbeugung arterieller restenose

Info

Publication number: ATE141054T1
Authority: AT; Austria
Prior art keywords: derivatives; hyaluronic acid; arterial restenosis; prevent arterial; prevent
Prior art date: 1992-09-25

Application number

AT93920624T

Other languages

English (en)

Inventor

Rudolf Edgar Falk

Samuel Simon Asculai

Eva Anne Turley

Original Assignee

Hyal Pharma Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-09-25

Filing date

1993-09-22

Publication date

1996-08-15

1993-09-22 Application filed by Hyal Pharma Corp filed Critical Hyal Pharma Corp

1996-08-15 Application granted granted Critical

1996-08-15 Publication of ATE141054T1 publication Critical patent/ATE141054T1/de

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Materials For Medical Uses (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Saccharide Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

AT93920624T 1992-09-25 1993-09-22 Verwendung von hyaluronsäure und derivate zur vorbeugung arterieller restenose ATE141054T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CA002079205A CA2079205C (en)	1992-09-25	1992-09-25	Use of hyaluronic acid and forms to prevent arterial restenosis

Publications (1)

Publication Number	Publication Date
ATE141054T1 true ATE141054T1 (de)	1996-08-15

Family

ID=4150463

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT93920624T ATE141054T1 (de)	1992-09-25	1993-09-22	Verwendung von hyaluronsäure und derivate zur vorbeugung arterieller restenose

Country Status (26)

Country	Link
EP (1)	EP0661981B1 (de)
JP (1)	JP3742955B2 (de)
CN (1)	CN1057908C (de)
AP (1)	AP448A (de)
AT (1)	ATE141054T1 (de)
AU (1)	AU670117B2 (de)
BR (1)	BR9307221A (de)
CA (1)	CA2079205C (de)
CZ (1)	CZ288986B6 (de)
DE (1)	DE69303931T2 (de)
DK (1)	DK0661981T3 (de)
ES (1)	ES2091031T3 (de)
GR (1)	GR3021171T3 (de)
HK (1)	HK35397A (de)
HU (2)	HU227067B1 (de)
IL (1)	IL107087A0 (de)
IN (1)	IN181289B (de)
MD (1)	MD960294A (de)
MX (1)	MX9305887A (de)
NO (1)	NO309457B1 (de)
NZ (1)	NZ255978A (de)
PL (1)	PL308201A1 (de)
SG (1)	SG48845A1 (de)
SK (1)	SK36895A3 (de)
TW (1)	TW271401B (de)
ZA (1)	ZA937068B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5811447A (en)	1993-01-28	1998-09-22	Neorx Corporation	Therapeutic inhibitor of vascular smooth muscle cells
US6515009B1 (en)	1991-09-27	2003-02-04	Neorx Corporation	Therapeutic inhibitor of vascular smooth muscle cells
US6491938B2 (en)	1993-05-13	2002-12-10	Neorx Corporation	Therapeutic inhibitor of vascular smooth muscle cells
US6663881B2 (en)	1993-01-28	2003-12-16	Neorx Corporation	Therapeutic inhibitor of vascular smooth muscle cells
US5981568A (en)	1993-01-28	1999-11-09	Neorx Corporation	Therapeutic inhibitor of vascular smooth muscle cells
US6387413B1 (en) *	1997-08-22	2002-05-14	Denki Kagaku Kogyo Kabushiki Kaisha	Hyaluronic acid gel, a method of its production and medical material containing it
FR2813791B1 (fr)	2000-09-14	2004-03-12	Lafon Labor	Utilisation de 2- et 4-quinolones pour inhiber la neo-proliferation intimale
FR2994846B1 (fr)	2012-08-29	2014-12-26	Vivacy Lab	Composition, sterilisee, comprenant au moins un acide hyaluronique et de l'ascorbyl phosphate de magnesium

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1340994C (en) *	1989-09-21	2000-05-16	Rudolf Edgar Dr. Falk	Treatment of conditions and disease

1992
- 1992-09-25 CA CA002079205A patent/CA2079205C/en not_active Expired - Lifetime
1993
- 1993-09-22 JP JP50854394A patent/JP3742955B2/ja not_active Expired - Lifetime
- 1993-09-22 DK DK93920624.9T patent/DK0661981T3/da active
- 1993-09-22 MD MD96-0294A patent/MD960294A/ro not_active Application Discontinuation
- 1993-09-22 NZ NZ255978A patent/NZ255978A/en not_active IP Right Cessation
- 1993-09-22 AU AU48126/93A patent/AU670117B2/en not_active Expired
- 1993-09-22 BR BR9307221A patent/BR9307221A/pt not_active Application Discontinuation
- 1993-09-22 PL PL93308201A patent/PL308201A1/xx unknown
- 1993-09-22 SK SK368-95A patent/SK36895A3/sk unknown
- 1993-09-22 TW TW082107796A patent/TW271401B/zh active
- 1993-09-22 DE DE69303931T patent/DE69303931T2/de not_active Expired - Lifetime
- 1993-09-22 CZ CZ1995662A patent/CZ288986B6/cs not_active IP Right Cessation
- 1993-09-22 AP APAP/P/1993/000568A patent/AP448A/en active
- 1993-09-22 SG SG1996002824A patent/SG48845A1/en unknown
- 1993-09-22 ES ES93920624T patent/ES2091031T3/es not_active Expired - Lifetime
- 1993-09-22 EP EP93920624A patent/EP0661981B1/de not_active Expired - Lifetime
- 1993-09-22 AT AT93920624T patent/ATE141054T1/de active
- 1993-09-22 HU HU9500857A patent/HU227067B1/hu unknown
- 1993-09-23 IL IL107087A patent/IL107087A0/xx not_active IP Right Cessation
- 1993-09-24 MX MX9305887A patent/MX9305887A/es unknown
- 1993-09-24 ZA ZA937068A patent/ZA937068B/xx unknown
- 1993-09-24 CN CN93119844A patent/CN1057908C/zh not_active Expired - Fee Related
1995
- 1995-03-23 NO NO951122A patent/NO309457B1/no not_active IP Right Cessation
- 1995-06-13 IN IN670CA1995 patent/IN181289B/en unknown
- 1995-06-30 HU HU95P/P00651P patent/HU211698A9/hu unknown
1996
- 1996-09-26 GR GR960402522T patent/GR3021171T3/el unknown
1997
- 1997-03-20 HK HK35397A patent/HK35397A/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
IL107087A0 (en)	1993-12-28
HU211698A9 (en)	1995-12-28
EP0661981A1 (de)	1995-07-12
SK36895A3 (en)	1997-03-05
AU670117B2 (en)	1996-07-04
DK0661981T3 (da)	1996-12-23
HK35397A (en)	1997-03-27
HUT73637A (en)	1996-08-28
PL308201A1 (en)	1995-07-24
NO309457B1 (no)	2001-02-05
EP0661981B1 (de)	1996-08-07
NO951122L (no)	1995-03-23
CA2079205C (en)	1998-02-10
IN181289B (de)	1998-05-02
AU4812693A (en)	1994-04-26
CN1057908C (zh)	2000-11-01
CN1092654A (zh)	1994-09-28
BR9307221A (pt)	1999-07-27
MX9305887A (es)	1994-05-31
DE69303931D1 (de)	1996-09-12
HU9500857D0 (en)	1995-05-29
SG48845A1 (en)	1998-05-18
AP9300568A0 (en)	1993-10-31
CZ288986B6 (cs)	2001-10-17
NO951122D0 (no)	1995-03-23
CZ66295A3 (en)	1996-02-14
JPH08506797A (ja)	1996-07-23
DE69303931T2 (de)	1997-01-09
TW271401B (de)	1996-03-01
ZA937068B (en)	1994-04-18
MD960294A (ro)	1997-10-31
ES2091031T3 (es)	1996-10-16
CA2079205A1 (en)	1994-03-26
AP448A (en)	1996-01-18
GR3021171T3 (en)	1996-12-31
JP3742955B2 (ja)	2006-02-08
NZ255978A (en)	1997-02-24
HU227067B1 (en)	2010-06-28

Similar Documents

Publication	Publication Date	Title
DE69223157D1 (de)	1997-12-18	Sauerstoff-substituierte derivate von nucleophil-stickstoffoxid-addukten und ihre verwendung als stickstoffoxid-donor-prodrugs
DE69133471D1 (de)	2005-07-21	Azolderivate und ihre Verwendung als Inhibitoren von Superoxidradikalen
DE69034018D1 (de)	2002-12-19	Kombinierte verwendung von hyaluronsäure und therapeutischen wirkstoffen zur verbesserung des therapeutischen effekts
DE19975068I2 (de)	2002-10-10	Derivate und Analoge der 2-Deoxy-2,3-Didehydro-N-Acetyl-Neuraminsaeure und ihre Verwendung als antivirale Agentien
FI954718A (fi)	1995-10-04	Heterosykliset johdannaiset iskeemian ja vastaavien sairauksien hoitamiseksi
DE69232252D1 (de)	2002-01-17	Herstellung und Verwendung von aktivierten Carbamaten
FI933510A (fi)	1994-02-12	Graensytaktiva foereningar baserade pao modifierade risinoljefettderivat
DE69840526D1 (de)	2009-03-19	Verwendung von inhaliertem stickstoffmonoxid als entzündungshemmendes agens
DE69119185D1 (de)	1996-06-05	Derivate von Carboxymethyl-Chitin und ihre Verwendung
DE69636792D1 (de)	2007-02-08	Verwendung von l-carnitine und acyl derivaten zur senkung des ceramidspiegels
ATE198275T1 (de)	2001-01-15	Subkutane implantate bestehend aus nomgestrolderivaten
FI932933A (fi)	1993-12-27	Tvaostegsraffinoer med variabel intensitet
DE69808266D1 (de)	2002-10-31	Herstellung und verwendung von alpha-ketoamid derivate und anordnunge
ITMI942156A0 (it)	1994-10-21	Derivati dell'acido p-amminopropionico ad attivita' fungicida
DE69303931D1 (de)	1996-09-12	Verwendung von hyaluronsäure und derivate zur vorbeugung arterieller restenose
DE69331105D1 (de)	2001-12-13	Verwendung von thioureleyne und thiabendazol in auto immunbedingten und entzündlichen hauterkrankungen
DE69420095D1 (de)	1999-09-23	Derivate von Polysacchariden, ihre Herstellung und Verwendung
DE59408857D1 (de)	1999-12-02	Vorrichtung zur kontinuierlichen Herstellung von Polyacetalen und ihre Verwendung
ATA901688A (de)	1993-03-15	Cyclodextrinclathrate von 5-cyanoprostacyclinderivaten und ihre verwendung als arzneimittel
DE59606616D1 (de)	2001-04-26	Dicarbonsäurederivate und ihre Verwendung zur Herstellung von Poly-o-hydroxyamiden oder Poly-o-mercaptoamiden
DE69313316D1 (de)	1997-10-02	Verwendung von Oxazopyrrolochinolinen und Pyrrolochinolonchinonen zur Herstellung von Produktionsbeschleunigern von Nervenwachstumsfaktoren g
NO934317D0 (no)	1993-11-29	Anvendelse av visse metanbisfosfonsyrederivater i brudd-heling
DE59508900D1 (de)	2001-01-18	Verwendung von Dibrom-thiophen-carbonsäure-Derivaten als Mikrobizide
DE59605796D1 (de)	2000-09-28	Oximether- und acrylsäurederivate und ihre verwendung als fungizide
DE69326437D1 (de)	1999-10-21	Verwendung von flavin-derivaten zur herstellung von medizinisch-chirugischen hygieneartikeln und die so erhaltenen hygieneartikel

Legal Events

Date	Code	Title	Description
1997-03-15	UEP	Publication of translation of european patent specification
2006-04-15	EEIH	Change in the person of patent owner